A carregar...
The development of an effective synthetic route of lesinurad (RDEA594)
BACKGROUND: Lesinurad is a novel selective uric acid salt transport protein 1 (URAT1) inhibitor which is approved in the USA for the treatment of gout. However, there are some shortcomings among the reported synthetic routes, such as expensive materials, environmental pollution and poor yield. RESUL...
Na minha lista:
| Publicado no: | Chem Cent J |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer International Publishing
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5583131/ https://ncbi.nlm.nih.gov/pubmed/29086884 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13065-017-0316-y |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|